Organogenesis Holdings (ORGO) FCF Margin (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly FCF Margin of 48.3% for Q1 2026, up 7548.0% year-over-year from 0.63% in Q1 2025, and up 213.41% quarter-over-quarter from 15.41% in Q4 2025.
Organogenesis Holdings (ORGO) FCF Margin (2017 - 2026) Analysis & Trends
Organogenesis Holdings' FCF Margin history runs 10 years deep, the most recent figure standing at 48.3% for Q1 2026.
- In Q1 2026, FCF Margin rose 7548.0% year-over-year to 48.3%; the TTM figure through Mar 2026 stood at 3.32% (up 516.0% YoY), while the FY2025 annual figure was 4.34%, down 520.0% from the prior year.
- FCF Margin for Q1 2026 stood at 48.3%, up from 15.41% in the prior quarter.
- The five-year high for FCF Margin was 48.3% in Q1 2026, with the low at 36.15% in Q2 2025.
- The 5-year median for FCF Margin is 0.47% (2022), against an average of 0.09%.
- The sharpest annual moves came in 2025 and 2026: FCF Margin slumped 3724 bps in 2025, then jumped 7548 bps in 2026.
- Organogenesis Holdings' FCF Margin stood at 2.47% in 2022, then surged by 396 bps to 7.32% in 2023, then declined by 18 bps to 5.98% in 2024, then surged by 158 bps to 15.41% in 2025, then jumped by 213 bps to 48.3% in 2026.
- Business Quant data shows ORGO's FCF Margin at 48.3% in Q1 2026, 15.41% in Q4 2025, and 0.56% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -74.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74.86% |
| Mar 31, 2026 | 48.30% |
| Dec 31, 2025 | 15.41% |
| Sep 30, 2025 | 0.56% |
| Jun 30, 2025 | -36.15% |
| Mar 31, 2025 | -27.18% |
| Dec 31, 2024 | 5.98% |
| Sep 30, 2024 | 5.32% |
| Jun 30, 2024 | 1.09% |
| Mar 31, 2024 | -9.95% |
| Dec 31, 2023 | 7.32% |
| Sep 30, 2023 | -2.23% |
| Jun 30, 2023 | 7.46% |
| Mar 31, 2023 | -6.56% |
| Dec 31, 2022 | -2.47% |
| Sep 30, 2022 | -4.24% |
| Jun 30, 2022 | -0.64% |
| Mar 31, 2022 | -0.47% |
| Dec 31, 2021 | 9.95% |
| Sep 30, 2021 | 9.80% |